D. Stein, Y. He, A. Phillips, B. Sahakian, J. Williams et al., Global mental health and neuroscience: potential synergies, 178?85. 3. DSM-V Diagnostic and Statistical Manual of Mental Disorders. 2013 e éd, 2015.
DOI : 10.1016/S2215-0366(15)00014-0

J. Bilello, L. Thurmond, K. Smith, B. Pi, R. Rubin et al., MDDScore, The Journal of Clinical Psychiatry, vol.76, issue.2, pp.199-206, 2015.
DOI : 10.4088/JCP.14m09029

URL : http://www.psychiatrist.com/JCP/article/_layouts/ppp.psych.controls/BinaryViewer.ashx?Article=/jcp/article/pages/2015/v76n02/v76n0211.aspx&Type=Article

T. Huang and C. Lin, Advances in Biomarkers of Major Depressive Disorder, Adv Clin Chem, vol.68, pp.177-204, 2015.
DOI : 10.1016/bs.acc.2014.11.003

A. Lopresti, G. Maker, S. Hood, and P. Drummond, A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.48, pp.102-113, 2014.
DOI : 10.1016/j.pnpbp.2013.09.017

P. Boksa, A way forward for research on biomarkers for psychiatric disorders, Journal of Psychiatry & Neuroscience, vol.38, issue.2, pp.75-82, 2013.
DOI : 10.1503/jpn.130018

W. Kluge, M. Alsaif, P. Guest, E. Schwarz, and S. Bahn, Translating potential biomarker candidates for schizophrenia and depression to animal models of psychiatric disorders, Expert Review of Molecular Diagnostics, vol.61, issue.7, pp.721-754, 2011.
DOI : 10.1210/jcem-61-3-429

H. Schmidt, R. Shelton, R. Duman, M. Millan, S. Bahn et al., Functional biomarkers of depression: diagnosis, treatment, and pathophysiology Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank, Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. nov Int J Neuropsychopharmacol Off Sci J Coll Int Neuropsychopharmacol CINP, vol.3618, issue.1210, 2011.

I. Vaz-luis, E. Winer, and N. Lin, Human epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes?, Annals of Oncology, vol.108, issue.Suppl, pp.283-91, 2013.
DOI : 10.1007/s10549-007-9596-6

URL : https://academic.oup.com/annonc/article-pdf/24/2/283/13788703/mds286.pdf

M. Oquendo, P. Mcgrath, M. Weissman, R. Schwan, K. Angioi-duprez et al., but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia Biomarker studies and the future of personalized treatment for depression The cannabinoid system and visual processing: a review on experimental findings and clinical presumptions, Cerebrospinal fluid levels of ?-amyloid 1-42):98?106. 13, pp.100-112, 2012.

M. Hoon, H. Okawa, D. Santina, L. Wong, and R. , Functional architecture of the retina: Development and disease, Progress in Retinal and Eye Research, vol.42, 2014.
DOI : 10.1016/j.preteyeres.2014.06.003

M. Livingstone and D. Hubel, Segregation of form, color, movement, and depth: anatomy, physiology, and perception, 740?9. 18. Nowak LG, James AC, Bullier J. Corticocortical connections between visual areas 17, 1988.
DOI : 10.1126/science.3283936

K. Palczewski, Chemistry and Biology of Vision, Journal of Biological Chemistry, vol.20, issue.3, pp.1612-1621, 2011.
DOI : 10.1001/archophthalmol.2010.245

J. Yoon, S. Sheremata, A. Rokem, M. Silver, G. Celesia et al., Windows to the soul: vision science as a tool for studying biological mechanisms of information processing deficits in schizophrenia International Federation of Clinical Neurophysiology. International Federation of Clinical Neurophysiology: recommendations for visual system testing, 1393?409. 22. Disney AA, Aoki C, Hawken MJ. Gain modulation by nicotine in macaque v1, 2010.

L. Busse and M. Carandini, GABAA Inhibition Controls Response Gain in Visual Cortex, 701?13. 23. Katzner S, pp.5931-5972, 2007.

D. Javitt, When doors of perception close: bottom-up models of disrupted cognition in schizophrenia Knight RA, Silverstein SM. A process-oriented approach for averting confounds resulting from general performance deficiencies in schizophrenia):15?30. 26. London A, Benhar I, Schwartz M. The retina as a window to the brain-from eye research to CNS disorders, Annu Rev Clin Psychol. J Abnorm Psychol. Nat Rev Neurol. janv, vol.51109, issue.11, pp.249-75, 2001.

P. Witkovsky, Dopamine and retinal function, 17?40. 28. Reis RAM, 2004.
DOI : 10.1023/B:DOOP.0000019487.88486.0a

N. Tian, T. Horvath, and D. Marshak, Retinopetal axons in mammals: emphasis on histamine and serotonin, Dopaminergic signaling in the developing retina):181?8. 29. Gastinger MJ, pp.7-8655, 2006.

S. Wu and B. Maple, Amino acid neurotransmitters in the retina: a functional overview, Vision Research, vol.38, issue.10
DOI : 10.1016/S0042-6989(97)00296-4

H. Betz, B. Laube, C. Souza, M. Acosta, P. Polkinghorne et al., The Glycine Receptor, 1600?10. 32, pp.113-133, 2006.
DOI : 10.1007/978-3-642-70940-1_13

J. Lavoie, M. Maziade, and M. Hébert, The brain through the retina: The flash electroretinogram as a tool to investigate psychiatric disorders, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.48, pp.129-163, 2014.
DOI : 10.1016/j.pnpbp.2013.09.020

V. Laprevote, T. Schwitzer, A. Giersch, R. Schwan, M. Karl et al., Flash electroretinogram and addictive disorders Ion channels in the RPE, 263?301. 37. Smith K. Mental health: a world of depression. Nature. 13 nov, p.181, 2007.

J. Pyne, T. Patterson, R. Kaplan, S. Ho, J. Gillin et al., Preliminary longitudinal assessment of quality of life in patients with major depression, Psychopharmacol Bull, vol.33, issue.1, pp.23-32, 1997.

D. Charney and H. Manji, Life Stress, Genes, and Depression: Multiple Pathways Lead to Increased Risk and New Opportunities for Intervention, Science Signaling, vol.344, issue.17, p.5, 2004.
DOI : 10.1056/NEJM200104263441703

M. Cano, N. Cardoner, M. Urretavizcaya, I. Martínez-zalacaín, X. Goldberg et al., Modulation of Limbic and Prefrontal Connectivity by Electroconvulsive Therapy in Treatment-resistant Depression: A Preliminary Study Fava M. Diagnosis and definition of treatment-resistant depression, 649?59. 42. Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression, 2003.

H. Kunugi, H. Hori, and S. Ogawa, Biochemical markers subtyping major depressive disorder In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature, 597?608. 45. Lener MS, Iosifescu DV, pp.50-65, 2015.

M. Kalia, E. Costa, J. Silva, . Sm, B. Keane et al., Vision science and schizophrenia research: toward a review of the disorder Editors' introduction to special section Standardized full-field electroretinography. Normal values and their variation with age):1571?6. 49. Silverstein SM, Rosen R. Schizophrenia and the eye Retinal dysfunctions in schizophrenia Light evoked potentials measured by electroretinogram may tap into the neurodevelopmental roots of schizophrenia, 681?9. 48. Birch DG297?300. 51. Hébert M):294?5. 52. Seidman LJ, Nordentoft M. New Targets for Prevention of Schizophrenia: Is It Time for Interventions in the Premorbid Phase, pp.46-55, 1960.

E. Bubl, D. Ebert, E. Kern, L. Van-elst, M. Bach et al., Effect of antidepressive therapy on retinal contrast processing in depressive disorder Neurobiology of retinal dopamine in relation to degenerative states of the tissue, Br J Psychiatry J Ment Sci. août Vision Res. déc, vol.20137, issue.56, 1997.

S. Massey and R. Miller, N-methyl-D-aspartate receptors of ganglion cells in rabbit retina, Journal of Neurophysiology, vol.63, issue.1, pp.16-30, 1990.
DOI : 10.1152/jn.1990.63.1.16